Synergistic effect of human umbilical cord mesenchymal stem cells and platelet-rich plasma on promoting healing of Achilles tendon injury in rats

Wei Wang; Yuchong Fu; Mei Zhou; Hong Tang; Jiqiang Zhang; Kanglai Tang

doi:10.16016/j.1000-5404.201607181

您当前的位置：

首页 >

文章列表页 >

Synergistic effect of human umbilical cord mesenchymal stem cells and platelet-rich plasma on promoting healing of Achilles tendon injury in rats

Basic Medicin | 更新时间：2020-08-05

- Synergistic effect of human umbilical cord mesenchymal stem cells and platelet-rich plasma on promoting healing of Achilles tendon injury in rats
- J Third Mil Med Univ Vol. 39, Issue 2, Pages: 185-191(2017)
- 作者机构：
  
  1.400038 重庆, 第三军医大学: 西南医院骨科, 全军矫形外科中心
  2.400038 重庆, 第三军医大学: 基础医学部神经生物学教研室
- 作者简介：
- 基金信息：
  
  Supported by the “Twelfth Five-year Plan” of Medical Research Foundation of PLA(创新专项重点 13CXZ008)
- DOI：10.16016/j.1000-5404.201607181
  CLC： R329.2;R686.1;R977.8
- Published：30 January 2017，
  
  Received：26 July 2016，
  
  Accepted：4 September 2016
扫描看全文
Wei Wang, Yuchong Fu, Mei Zhou, et al. Synergistic effect of human umbilical cord mesenchymal stem cells and platelet-rich plasma on promoting healing of Achilles tendon injury in rats. [J]. J Third Mil Med Univ 39(2):185-191(2017)
DOI：

Wei Wang, Yuchong Fu, Mei Zhou, et al. Synergistic effect of human umbilical cord mesenchymal stem cells and platelet-rich plasma on promoting healing of Achilles tendon injury in rats. [J]. J Third Mil Med Univ 39(2):185-191(2017) DOI： 10.16016/j.1000-5404.201607181.

摘要

目的

探讨不同浓度富含血小板血浆(platelet-rich plasma，PRP)在体外对人脐带间充质干细胞(human umbilical cord mesenchymal stem cells，hUC-MSCs)增殖、分化的影响，评估hUC-MSCs联合PRP对大鼠跟腱损伤修复的影响。

方法

PRP活化后成为PRP-clot releasate(PRCR)。取P3代hUC-MSCs于培养皿中培养24 h后，分别加入含0%(对照组)、10%、20%、40% PRCR的DMEM/F12培养基，于第1、2、3、4天测定hUC-MSCs的增殖速度。P3代hUC-MSCs按相同分组培养，于第1、3、5天收集细胞并提取蛋白。Western blot检测hUC-MSCs中成肌腱分化标志性基因肌腱蛋白C(tenascin c

TNC)、SCX(scleraxis)、Ⅰ型胶原的表达。选取48只8周龄雄性SD大鼠，Ⅰ型胶原酶溶液50 μL注射于大鼠右侧跟腱制备跟腱损伤模型，3 d后于损伤部位再次分别注射50 μL生理盐水(对照)、hUC-MSCs悬液、PRP或PRP+hUC-MSCs混悬液，术后2、4周安乐死大鼠，Western blot检测跟腱中TNC、SCX及Ⅰ型胶原的表达，跟腱切片HE染色行组织学评估。

结果

PRCR在体外对hUC-MSCs增殖均有促进作用，20% PRCR组促增殖作用最显著(

＜0.05)；20% PRCR组较对照组在体外可以显著地促进hUC-MSCs成肌腱分化标志性基因的表达(

＜0.05)；术后2、4周，PRP+hUC-MSCs组跟腱中成肌腱分化相关基因在蛋白水平表达更高，跟腱切片HE染色显示PRP+hUC-MSCs组纤维排列更规整，炎细胞更少。

结论

适宜浓度PRP在体外显著促进了hUC-MSCs的增殖、成肌腱分化；PRP联合hUC-MSCs能有效促进大鼠受损跟腱的修复。

Abstract

Objective

To determine the effect of different concentrations of platelet-rich plasma (PRP) on the proliferation and differentiation of human umbilical cord mesenchymal stem cells (HUC-MSCs)

in vitro

and evaluate the effect of hUC-MSCs combined with PRP in the treatment of collagenase-induced Achilles tendon injury in rats.

Methods

PRP was activated to prepare into PRP-clot releasate (PRCR). hUC-MSCs at passage 3 were incubated in control medium or medium supplemented with 10%

20% or 40% PRCR

and the proliferation of hUC-MSCs on days 1

3 and 4 was evaluated. Tenogenesis related genes (scleraxis

tenascin-C

and collagen typeⅠ) were assessed by Western blotting on days 1

3 and 5. In 2 and 4 weeks after hUC-MSCs

PRP

hUC-MSCs+PRP or saline (as control) injection into the injured Achilles tendon

the tendon tissue was harvested and evaluated by histology and Western blotting.

Results

PRCR promoted the proliferation of hUC-MSCs

in vitro

and 20% PRCR prominently increased the number of hUC-MSCs (

＜0.05) as well as the protein levels of collagen typeⅠ

tenascin-C and scleraxis (

＜0.05). Combination of hUC-MSCs and PRP resulted in better healing effect of the injured tendon by improving histological characteristics and increasing expression of tenogenesis related genes in 2 and 4 weeks after operation.

Conclusion

Appropriate concentration of PRP promotes the proliferation and tenogenic differentiation of hUC-MSCs. Combination of hUC-MSCs and PRP has synergistic effect on promoting healing of the injured Achilles tendon.

关键词

人脐带间充质干细胞富含血小板血浆大鼠模型跟腱损伤

Keywords

human umbilical cord mesenchymal stem cellsplatelet-rich plasmarat modelAchilles tendon injury

references

Petrou I G, Grognuz A, Hirt-Burri N, et al. Cell therapies for tendons: old cell choice for modern innovation[J]. Swiss Med Wkly, 2014, 144:w13989. DOI: 10.4414/smw.2014.13989

Lee J S, Hong J M, Moon G J, et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke[J]. Stem Cells, 2010,28(6):1099-1106. DOI: 10.1002/stem.430

Renzi S, Riccò S, Dotti S, et al. Autologous bone marrow mesenchymal stromal cells for regeneration of injured equine ligaments and tendons: a clinical report[J]. Res Vet Sci, 2013,95(1): 272-277. DOI: 10.1016/j.rvsc.2013.01.017

Lee S Y, Kim W, Lim C, et al. Treatment of Lateral Epicondylosis by Using Allogeneic Adipose-Derived Mesenchymal Stem Cells: A Pilot Study[J]. Stem Cells, 2015,33(10): 2995-3005. DOI: 10.1002/stem.2110

Lui P P, Kong S K, Lau P M, et al. Allogeneic tendon-derived stem cells promote tendon healing and suppress immunoreactions in hosts:in vivo model[J]. Tissue Eng Part A, 2014, 20(21/22): 2998-3009. DOI: 10.1089/ten.TEA.2013.0713

Lin Y M, Wu C C, Chang Y C, et al. Target disruption of ribosomal protein pNO40 accelerates aging and impairs osteogenic differentiation of mesenchymal stem cells[J]. Biochem Biophys Res Commun, 2016, 469(4): 903-910. DOI: 10.1016/j.bbrc.2015.12.003

Ding D C, Chang Y H, Shyu W C, et al. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy[J]. Cell Transplant, 2015, 24(3): 339-347. DOI: 10.3727/096368915X686841

Zhang J, Wang J H. Platelet-rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes[J]. Am J Sports Med, 2010, 38(12): 2477-2486. DOI: 10.1177/0363546510376750

González J C, López C, álvarez M E, et al. Autologous leukocyte-reduced platelet-rich plasma therapy for Achilles tendinopathy induced by collagenase in a rabbit model[J]. Sci Rep, 2016, 6: 19623. DOI: 10.1038/srep19623

Mishra A, Randelli P, Barr C, et al. Platelet-rich plasma and the upper extremity[J]. Hand Clin, 2012, 28(4): 481-491. DOI: 10.1016/j.hcl.2012.08.008

Mishra A K, Skrepnik N V, Edwards S G, et al. Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients[J]. Am J Sports Med, 2014, 42(2): 463-471. DOI: 10.1177/0363546513494359

Di M B, Filardo G, Kon E, et al. Platelet-rich plasma: evidence for the treatment of patellar and Achilles tendinopathy—a systematic review[J]. Musculoskelet Surg, 2015, 99(1): 1-9. DOI: 10.1007/s12306-014-0340-1

Giusti I, D'Ascenzo S, Mancò A, et al. Platelet concentration in platelet-rich plasma affects tenocyte behavior in vitro[J]. Biomed Res Int, 2014, 2014: 630870. DOI: 10.1155/2014/630870

Giusti I, Rughetti A, D'Ascenzo S, et al. Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells[J]. Transfusion, 2009, 49(4): 771-778. DOI: 10.1111/j.1537-2995.2008.02033.x

Tsai Y P, Chang C W, Lee J S, et al. Direct radiofrequency application improves pain and gait in collagenase-induced acute achilles tendon injury[J]. Evid Based Complement Alternat Med, 2013,2013:402692. DOI: 10.1155/2013/402692

Shah V, Bendele A, Dines J S, et al. Dose-response effect of an intra-tendon application of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) in a rat Achilles tendinopathy model[J]. J Orthop Res, 2013, 31(3): 413-420. DOI: 10.1002/jor.22222

Chen J, Yu Q, Wu B, et al. Autologous tenocyte therapy for experimental Achilles tendinopathy in a rabbit model[J]. Tissue Eng Part A, 2011, 17(15/16): 2037-2048. DOI: 10.1089/ten.TEA.2010.0492

Mennan C, Wright K, Bhattacharjee A, et al. Isolation and characterisation of mesenchymal stem cells from different regions of the human umbilical cord[J]. Biomed Res Int, 2013, 2013: 916136. DOI: 10.1155/2013/916136

Hsieh J Y, Fu Y S, Chang S J, et al. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord[J]. Stem Cells Dev, 2010,19(12): 1895-1910. DOI: 10.1089/scd.2009.0485

Burk J, Ribitsch I, Gittel C, et al. Growth and differentiation characteristics of equine mesenchymal stromal cells derived from different sources[J]. Vet J, 2013,195(1): 98-106. DOI: 10.1016/j.tvjl.2012.06.004

Zhang L, Chen S, Chang P, et al. Harmful Effects of Leukocyte-Rich Platelet-Rich Plasma on Rabbit Tendon Stem CellsIn Vitro[J]. Am J Sports Med, 2016. DOI: 10.1177/0363546516644718

Dragoo J L, Braun H J, Durham J L, et al. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons[J]. Am J Sports Med, 2012, 40(6): 1274-1281. DOI: 10.1177/0363546512442334

Cross J A, Cole B J, Spatny K P, et al. Leukocyte-Reduced Platelet-Rich Plasma Normalizes Matrix Metabolism in Torn Human Rotator Cuff Tendons[J]. Am J Sports Med, 2015, 43(12): 2898-2906. DOI: 10.1177/0363546515608157

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Establishment of rat model of sarcopenia by ovariectomy and estrogen replacement therapy

uman umbilical cord mesenchymal stem cell-derived exosomes alleviate renal ischemia/reperfusion injury in rats by regulating SLC7A11/GPX4 pathway

Effect and mechanism of human umbilical cord mesenchymal stem cells on preventing murine acute graft-versus-host disease

Curcumin inhibits tumor necrosis factor-α-induced apoptosis of human umbilical cord mesenchymal stem cells in vitro

Effects of calcitonin gene-related peptide on osteogenic differentiation of human umbilical cord mesenchymal stem cells

Related Author

XIONG Zheng’ai

LING Li

HUANG Yubin

YUAN Yuan

GUO Wenwen

WANG Hao

LI Lingyu

LUO Hao

Related Institution

Department of Gynecology and Obstetrics, the Second Affiliated Hospital of Chongqing Medical University

兰州大学：第一临床医学院，第一医院日间手术中心

陆军军医大学（第三军医大学）第二附属医院血液病医学中心，全军血液病中心，创伤、烧伤与复合伤国家重点实验室1

遵义医科大学第二附属医院检验科2

陆军军医大学（第三军医大学）基础医学院细胞生物学教研室3

⁰